A Systems-Based Approach to Digital Design & Operation

About the Author

Robert H. Peeling, CEng, FIChemE, is a chemical engineer and Fellow of the Institution of Chemical Engineers. A Senior Innovation Specialist at Britest Limited, he...

Charles M. Gordon, PhD

Charles M. Gordon, PhD, joined Britest Limited as a Senior Innovation Specialist in 2011, having previously worked as a reaction engineer in API process development...

Martin R. Edwards, PhD

Martin R. Edwards, PhD, is a Senior Innovation Specialist at Britest Limited and has spent more than 25 years in the chemical industry, leading product...

John A. Henderson, CChem, PhD

John A. Henderson, CChem, PhD, is Technical Communications Specialist at Britest Limited. He is a Chartered Chemist with an honors degree in applied chemistry from...

Sean Bermingham

VP Life Sciences

Process Systems Enterprise Ltd

Sean K. Bermingham, PhD, has been Head of Process Systems Enterprise’s Formulated Products business unit since 2010 and previously was Global Head of Consulting. He...

Technical

Selection Criteria for Pharmaceutical Containment Equipment

1 March 2024

Pharmaceutical manufacturing facilities produce a variety of products, including highly potent products that require safety measures to prevent adverse health effects on patients and operators. To ensure safety, these facilities use containment equipment to minimize the risk of contamination. This article presents criteria for selecting containment equipment, considering both...

Technical

A Sustainable Approach to Steam Quality Management

1 March 2024

The world is beginning to grasp the huge challenge of achieving net-zero carbon emissions, or carbon neutrality, by 2050. Many countries have committed to achieving this ambitious goal. As a major global industry, the pharmaceutical sector has a significant role to play. For thermal energy–intensive industries, such as pharmaceutical manufacturing, the long-term future options to maintain...

Technical

Concluding Compliance Challenges with Validation 4.0

13 March 2024

As the pharma industry moves to an ambitious Validation 4.0 paradigm, computerized systems play a pivotal role in enabling the rapid transition. Innovation and agility in computerized system validation (CSV) received a strong push in the second half of 2022 with the publication of the FDA draft guidance on “Computer Software Assurance for Production and Quality System Software”

About the Author

Facilities of the Future: Meeting the Demands of Breakthrough Therapeutics

Emerging Leader Hacker to GAMPer in 10 Weeks

New Initiative Seeks to Back up ICHs Harmonization Mission

Data Science-Assisted Biopharmaceutical Tech Transfer and Process Characterization

Entering a New Era of Innovation and Collaboration With the Focus on the Workforce of the Future

Q&A with ISPE Foundation Professional Development Grant Recipient Silas Tamufor

Related Articles